TABATON, MASSIMO
 Distribuzione geografica
Continente #
EU - Europa 19.444
AS - Asia 1.709
NA - Nord America 756
SA - Sud America 154
AF - Africa 30
Totale 22.093
Nazione #
IT - Italia 19.137
SG - Singapore 767
US - Stati Uniti d'America 710
CN - Cina 463
VN - Vietnam 277
FR - Francia 159
BR - Brasile 99
HK - Hong Kong 66
DE - Germania 37
BD - Bangladesh 33
FI - Finlandia 32
AR - Argentina 27
JP - Giappone 21
CA - Canada 19
CH - Svizzera 17
IQ - Iraq 13
MX - Messico 13
IN - India 12
GB - Regno Unito 11
NL - Olanda 9
ID - Indonesia 8
ZA - Sudafrica 8
RU - Federazione Russa 7
CO - Colombia 6
EC - Ecuador 6
CL - Cile 5
EG - Egitto 5
IE - Irlanda 5
PK - Pakistan 5
PY - Paraguay 5
SA - Arabia Saudita 5
TH - Thailandia 5
UA - Ucraina 5
PH - Filippine 4
PL - Polonia 4
VE - Venezuela 4
AL - Albania 3
AZ - Azerbaigian 3
CR - Costa Rica 3
ES - Italia 3
HR - Croazia 3
JM - Giamaica 3
JO - Giordania 3
KE - Kenya 3
TN - Tunisia 3
TW - Taiwan 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
DZ - Algeria 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
MM - Myanmar 2
NI - Nicaragua 2
OM - Oman 2
RO - Romania 2
SE - Svezia 2
SN - Senegal 2
SV - El Salvador 2
TR - Turchia 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CD - Congo 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HU - Ungheria 1
KW - Kuwait 1
LU - Lussemburgo 1
MY - Malesia 1
NG - Nigeria 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SY - Repubblica araba siriana 1
ZM - Zambia 1
Totale 22.093
Città #
Genova 12.792
Genoa 3.730
Rapallo 1.513
Vado Ligure 996
Singapore 334
San Jose 280
Lauterbourg 155
Ho Chi Minh City 92
Ashburn 90
Hanoi 67
Hong Kong 63
New York 57
Bordighera 54
Beijing 53
Frankfurt am Main 33
Helsinki 32
Santa Clara 30
Tokyo 20
Zurich 17
Los Angeles 15
Tianjin 15
Council Bluffs 14
Da Nang 13
Haiphong 13
Amsterdam 9
Biên Hòa 9
Guangzhou 8
Orem 8
São Paulo 8
Mexico City 7
Phoenix 6
Rome 6
Thái Bình 6
Toronto 6
Bologna 5
Dallas 5
Dublin 5
Milan 5
Belo Horizonte 4
Cape Town 4
Cardiff 4
Catania 4
Chennai 4
Chicago 4
Des Moines 4
Warsaw 4
Amman 3
Baku 3
Brasília 3
Buffalo 3
Caracas 3
Concepción 3
Goiânia 3
Ha Long 3
Hải Dương 3
Juiz de Fora 3
Kingston 3
Madrid 3
Montreal 3
Nairobi 3
Ninh Bình 3
Quảng Ngãi 3
Seattle 3
Shenzhen 3
Taichung 3
Washington 3
Astana 2
Atlanta 2
Baghdad 2
Basra 2
Boardman 2
Brampton 2
Cachoeirinha 2
Cairo 2
Campanha 2
Can Tho 2
Casablanca 2
Changsha 2
Chongqing 2
City of London 2
Columbia 2
Curitiba 2
Dakar 2
Denver 2
Detroit 2
Fortaleza 2
Gangnam-gu 2
Guayaquil 2
Houston 2
Johannesburg 2
Kansas City 2
Lanús 2
Lấp Vò 2
Managua 2
Mazatlán 2
Medellín 2
Miami 2
Monte Grande 2
Morganfield 2
Naples 2
Totale 20.731
Nome #
17A, a novel non-coding RNA, regulates GABA B alternative splicing and signaling in response to inflammatory stimuli and in Alzheimer disease 251
Monomeric Aβ1-42 and RAGE: key players in neuronal differentiation 226
A novel presenilin 1 L166H mutation in a pseudo-sporadic case of early-onset Alzheimer's disease. 198
Amnestic mild cognitive impairment and conversion to Alzheimer's disease: insulin resistance and glycoxidation as early biomarker clusters. 194
Hereditary motor and sensory neuropathy with deafness, mental retardation and absence of large myelinated fibers. 191
Lipoperoxidation is selectively involved in progressive supranuclear palsy 190
Survival rate in Patients affected by Dementia followed by memory clinics (UVA) in Italy 186
Early glycoxidation damage in brains from Down’s syndrome 184
Artificial neural networks identify the predictive values of risk factors on the conversion of amnestic mild cognitive impairment. 184
Increase of cdk5 is related to neurofibrillary pathology in progressive supranuclear palsy 182
B-Amyloid 1-42 and RAGE play a key role in ATRA-induced neuronal differentiation 181
Direct immunofluorescence in sural nerve biopsies. 180
Balance features in Alzheimer's disease and amnestic mild cognitive impairment 179
Amyloid-β₄₂ activates the expression of BACE1 through the JNK pathway. 178
The increased activity of BACE1 correlates with oxidative stress in Alzheimer’s disease. 176
GFAP expression of human Schwann cells in tissue culture. 176
RNA polymerase III drives alternative splicing of the Potassium Channel Interacting Protein contributing to brain complexity and neurodegeneration 175
JNK and ERK1/2 pathways have a dual opposite effect on the expression of BACE1. 174
Alternative, non-secretase processing of Alzheimer’s b-amyloid precursor protein during apoptosis by Caspase-6 and-8 174
Abnormal tau-reactive filaments in olfactory mucosa in biopsy specimens of patients with probable Alzheimer's disease. 173
Beta-amyloid 1-42 monomers, but not oligomers, produce PHF-like conformation of Tau protein 170
Corticobasal degeneration shares a common genetic background with progressive supranuclear palsy 169
Oxidative stress induces increase in intracellular amyloid-protein production and selective activation of I and II PKCs in NT2 cells 169
Fibroblasts from FAD-linked presenilin 1 mutations display a normal unfolded protein response but overproduce Abeta42 in response to tunicamycin 168
Mutant presenilin 1 increases the expression and activity of BACE1. 167
Elevation of βAmyloid 1-42 Autoantibodies in the Blood of Amnestic Patients With Mild Cognitive Impairment. 167
Frontal Variant of Alzheimer's Disease: A Report of a Novel PSEN1 Mutation 167
The Unexpected Role of Aβ1-42 Monomers in the Pathogenesis of Alzheimer's Disease 164
Amyloid-beta42 plasma levels are elevated in amnestic mild cognitive impairment. 159
Motor and sensory evoked potentials in progressive supranuclear palsy. 159
Association of a presenilin 1 S170F mutation with a novel Alzheimer disease molecular phenotype 158
A novel origin for granulovacuolar degeneration in aging and Alzheimer's disease: parallels to stress granules 158
Possible Influence of a Non-Synonymous Polymorphism Located in the NGF Precursor on Susceptibility to Late-Onset Alzheimer's Disease and Mild Cognitive Impairment 156
Schwann cell GFAP expression increases in axonal neuropathies. 154
A silver lining for 24-hydroxycholesterol in Alzheimer's disease: The involvement of the neuroprotective enzyme sirtuin 1 154
Protein levels of glycogen synthase 3 kinase are normal in progressive supranuclear palsy. 153
Beta-Site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. 153
Oxidative stress increase expression and activity of BACE in NT2 neurons 153
HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins. 153
Upregulation of presenilin 1 in brains of sporadic, late-onset Alzheimer's disease 151
Amyloid-b deposition in Alzheimer transgenic mice is associated with oxidative stress. 149
The H1 haplotype of the tau gene (MAPT) is associated with mild cognitive impairment 149
Position paper of the Italian Society for the study of Dementias (Sindem) on the proposal of a new Lexicon on Alzheimer disease. 148
Beta-amyloid is different in normal aging and in Alzheimer's disease 148
Aβ 1-42-mediated down-regulation of Uch-L1 is dependent on NF-κB activation and impaired BACE1 lysosomal degradation. 148
A quantitative and ultrastructural study of substantia nigra and nucleus centralis superior in Alzheimer's disease. 147
AGEs/RAGE complex upregulates BACE1 via NF-κB pathway activation 147
Office of Rare Diseases neuropathologic criteria for corticobasal degeneration 146
Increased amyloidogenic secretion in cerebellar granule cells undergoing apoptosis 146
Relationship between Balance and Cognitive Performance in Older People 146
CSF and serum IgG and albumin in schizophrenics 146
Presence of soluble amyloid beta peptide precedes amyloid plaque formation in Down's syndrome 145
Oxidative damage in the olfactory system in Alzheimer’s disease. 144
Full length alpha-synuclein is present in cerebrospinal fluid from Parkinson's disease and normal subjects 143
Amyloid-β Production: Major Link Between Oxidative Stress and BACE1. 143
The Decrease of Uch-L1 Activity Is a Common Mechanism Responsible for Aβ 42 Accumulation in Alzheimer's and Vascular Disease 143
Role of water-soluble amyloid-beta in the pathogenesis of Alzheimer's disease. 142
The 14-3-3 protein in multiple sclerosis: a marker of disease severity. 142
Creutzfeldt-Jakob disease in the city and district of Genoa: estimated mortality rate in the six year period 1974-1979. 142
Neuronal apoptosis is accompanied by selective intracellular A-beta production and APP caspase cleavage 142
Dual Mechanism of Toxicity for Extracellular Injection of Tau Oligomers versus Monomers in Human Tau Mice 141
Oxidative stress mediates the pathogenic effect of different Alzheimer's disease risk factors. 140
Plasma levels of insulin and amyloid beta 42 are correlated in patients with amnestic Mild Cognitive Impairment 140
Early myoclonus and quasiperiodic EEG changes in non-familial Alzheimer's disease. 139
A novel mechanism of phenotypic heterogeneity demonstrated by the effect of a polymorphism on a pathogenic mutation in the PRNP (prion protein gene) 139
Peripheral neuropathy in Cockayne syndrome. 139
Heterogeneity of water-soluble amyloid b-peptide in Alzheimer’s disease and Down’s syndrome brains 138
Alz 50 recognizes abnormal filaments in Alzheimer's disease and progressive supranuclear palsy. 138
Opposite role of apolipoprotein E in normal brain and Alzheimer's disease 136
The Earliest Stage of Cognitive Impairment in Transition From Normal Aging to Alzheimer Disease Is Marked by Prominent RNA Oxidation in Vulnerable Neurons. 135
Amyloid beta protein deposition in brains from elderly subjects with leukoaraiosis. 135
Chronic oxidative stress causes increased tau phosphorylation in M17 neuroblastoma cells 134
Generation of an apoptotic intracellular peptdide by g-secretase cleavage of Alzheimer’s amyliod b-protein precursor. 133
Demonstration of a novel neurofilament associated antigen with the neurofibrillary pathology of Alzheimer and related diseases. 133
Oxidative stress in Alzheimer disease: A possibility for prevention. 131
Non traumatic dissecting aneurysm of the basilar artery 131
A simple, inexpensive, and precise spectrophotometric method for evaluating the concentration of ascorbic acid in CSF samples: data from different neurological pathologies. 131
Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism 130
Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus. 130
Microtubule reduction in Alzheimer’s disease and aging is independent of tau filament formation. 130
Microarray analysis in Alzheimer’s disease and normal aging 129
Oxidative stress and neuronal adaptation in Alzheimer disease : the role of SAPK pathways. 128
Regulation of glycogen synthase kinase-3beta by products of lipid peroxidation in human neuroblastoma cells 127
Tyrosine kinase A-Nerve Growth Factor receptor is antigenically present in dystrophic neurites from a variety of conditions but not in Alzheimer's disease. 126
The Cell Cycle Regulator Phosphorylated Retinoblastoma Protein Is Associated With Tau Pathology in Several Tauopathies 126
Soluble amyloid beta-protein is increased in frontotemporal dementia with tau gene mutations. 125
Mitochondrial abnormalities in Alzheimer disease. 125
Italian multicenter study of dementia: a pathologically verified case of Alzheimer disease. 125
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins. 125
Neurosyphilis presenting as a progressive supranuclear palsy 121
Skin fibroblasts in Huntington's disease. An electron microscopic study. 120
Periodic lateralized discharges in Creutzfeldt-Jakob disease: serial electroencephalographic studies. 120
Plasma levels of amyloid beta 40 and 42 are independent from apoE genotype and mental retardation in Down syndrome 120
AGEs/RAGE complex upregulates BACE1 via NF-kappaB pathway activation 119
Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. 119
Is amyloid beta-protein glycated in Alzheimer disease? 119
Neuropil threads of Alzheimer's disease show a marked alteration of the normal cytoskeleton. 119
Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (Progressive Supranuclear Palsy) 119
Zoster sine herpete causing encephalomyelitis. 118
Memantine: "hypothesis testing" not "disease modifying" in Alzheimer's disease. 117
Totale 15.010
Categoria #
all - tutte 62.961
article - articoli 62.961
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 125.922


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202174 0 0 0 0 0 0 0 0 0 0 0 74
2021/20222.016 67 134 160 259 87 98 91 507 86 221 70 236
2022/20231.825 199 123 11 164 305 344 22 139 340 8 154 16
2023/2024769 37 133 7 88 75 89 41 80 43 8 53 115
2024/20252.442 52 202 67 159 341 263 209 370 108 127 240 304
2025/20264.270 540 107 265 450 573 506 773 185 255 378 177 61
Totale 22.173